Strong annexin A2 expression in stromal cells was observed for all clinical stages of human ovarian cancer (stage I to IV) compared with normal ovaries, serous cystadenomas and borderline ovarian tumors. This evidence concerns the gene ANXA2 and serous cystadenoma.